Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
The present invention generally applies to the fixation of hollow organs such as the stomach or the baldder to an outer structure, e.g. to the abdominal wall. The main field of application is in particular the percutaneous endoscopic gastrostomy (PEG) sonde.
PEG-sondes are applied by various techniques, especially by the so-called pull-through and the direct punctation (or push) technique. The latter is predominantly applied, when a stenosis of the upper gastrointestinal tract by a tumor prohibits oral access due to the consumption of space, but also due to the fact that the pull-through method is discussed in the literature to cause inoculation metastasis.
Commercial Opportunities
On behalf of the RWTH Aachen University, PROvendis is seeking for interested companies for cooperation and/or licensing.
Current Status
A prototype has been built for demonstration. We are happy to inform you about the patent status.
Competitive Advantages
•Laminar fixation
•Only one puncture
•Low risk of infection
•Low risk of bleeding
•Time- and cost-saving
Diagnostic method for determining the presence of herpes B virus, of for determining the status of herpes B virus infection in primates and in humans, based on the detection of antibodies against herpes B virus
Shar-Pei Autoinflammatory Disease (SPAID) is a complex inflammatory disease. Typical signs are recurrent bouts of fever, inflammations of the ear, arthritis and a reddened skin. The dogs can also develop amyloidosis. Scientists at the University of Veterinary Medicine Hannover developed a genetic test for SPAID predisposition.
Oncolytic virotherapy for cancer has emerged as a novel and promising therapeutic approach to replace standard cancer therapies, which often provide limited efficacy at the cost of unpleasant or severe side effects. Here, a novel VSV/NDV hybrid virus was engineered that combines the advantages of both vesicular stomatitis virus (VSV) and Newcastle disease virus (NDV) vectors, while the safety concerns of both are eliminated.
Scientists of the MEET at Wilhelms University of Muenster developed a set of alkylsilyl complexes (MOSi) as elecrolyte additive, which enhance the performance of lithium ion batteries. Previous studies have shown that electrolyte additives based on metals and semimetals (LiBOB, Mg(TFSI)2, Al(TFSI)3) as well as additives containing trimethylsiloxyl (TMS) groups as ligands can have positive impact on the cycling performance of lithium ion battery cells due to solid electrolyte interphase (SEI) and/or cathode electrolyte interphase (CEI) film forming properties and/or scavenging properties towards acidic impurities. The results of LIB full-cells show a twofold cycle life compared to the standard electrolyte. The addition of the M(TMS)x based additives lowers the charge transfer impedance during prolonged cycling. MOSi leads to lithium ion batteries with enhanced anti fading performance.
A German patent application is pending. International applications are possible.
On behalf of the University Muenster, PROvendis offers access to rights for commercial use as well as the opportunity for further co-development.